|
|
 |
 |
|
|
 |
Directions for Use |
 |
|
|
 |
|
Soft tissue regeneration procedures in the oral cavity are demanding and technique sensitive. Predictable and optimal results depend on many factors including a number of patient variables, surgical technique and the selection and appropriate utilization of a graft material.
Based on data from clinical studies1,2,3, discussions with surgeons, and the consensus of eleven Round Table Conferences (2009-2011), the following technical guidelines should be considered to optimize clinical success with Mucograft®.
Patient Selection
-
Mucograft® is an effective alternative to autogenous grafts in the appropriate cases.1 As with any soft tissue grafting procedure, patient selection, surgical requirements and patient compliance with post-surgical instructions should be carefully considered.
-
In order to increase keratinized tissue (KT) with Mucograft®, select cases that have at least 1 mm of KT already present. Mucograft® has demonstrated comparable gains in KT when compared to autogenous grafts in these types of cases.2 The small band of keratinized tissue provides the cellular information necessary to signal regeneration of the desired tissue type.
-
Patient goals and expectations in terms of esthetic and clinical outcomes should be considered and managed.
Product Handling
-
Mucograft® is ready to use without any time consuming preparatory steps. Mucograft® can be applied directly from the package to the surgical site. No washing or soaking of the matrix is necessary.
-
Mucograft® should be trimmed to size and applied dry. To avoid unnecessary wetting, the use of a template is recommended to achieve the proper size and shape.

-
When applied to the defect in its dry state to the defect, the matrix will rapidly moisten with blood. The soaked Mucograft® will adapt spontaneously to the defect contours and adhere well to the defect. Once saturated with blood, care should be taken to avoid unneccessary manipulation of the matrix which may lead to separation of the collagen fibers.

-
The compact structure should face outwards and the spongy structure should face towards the bone and/or periosteum.
-
Avoid compression of the matrix as much as possible. Creation of a tension free flap is critical when using Mucograft®. If possible, wider than normal flaps are recommended. Avoid post-surgical compression of the wound.
-
Mucograft® should be immobilized when implanted to stabilize the blood clot

| | | |